These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 25015549

  • 1. Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.
    Shin EA, Sohn EJ, Won G, Choi JU, Jeong M, Kim B, Kim MJ, Kim SH.
    Oncotarget; 2014 Jul 30; 5(14):5624-36. PubMed ID: 25015549
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D, Kwon HY, Sohn EJ, Nam MS, Kim JH, Lee JC, Ryu SY, Park B, Kim SH.
    Cell Physiol Biochem; 2015 Jul 30; 36(3):1151-62. PubMed ID: 26111475
    [Abstract] [Full Text] [Related]

  • 3. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.
    Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage.
    Ko H, Jeong MH, Jeon H, Sung GJ, So Y, Kim I, Son J, Lee SW, Yoon HG, Choi KC.
    Oncotarget; 2015 Apr 30; 6(12):9970-84. PubMed ID: 25991668
    [Abstract] [Full Text] [Related]

  • 7. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.
    Mol Cancer Res; 2008 Dec 30; 6(12):1852-60. PubMed ID: 19074830
    [Abstract] [Full Text] [Related]

  • 8. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L, Zongyuan Y, Cheng G, Lingyun Z, Guilian Y, Wei G.
    Cancer Sci; 2014 May 30; 105(5):520-7. PubMed ID: 24612139
    [Abstract] [Full Text] [Related]

  • 9. Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROS-dependent ER-stress.
    Moon DO, Park SY, Choi YH, Ahn JS, Kim GY.
    Biochem Pharmacol; 2011 Dec 01; 82(11):1641-50. PubMed ID: 21903093
    [Abstract] [Full Text] [Related]

  • 10. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5.
    Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ.
    Oncol Rep; 2007 Jan 01; 17(1):175-84. PubMed ID: 17143496
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5.
    Chen L, Wolff DW, Xie Y, Lin MF, Tu Y.
    BMC Cancer; 2017 Mar 07; 17(1):179. PubMed ID: 28270124
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 15. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C, Caruso R, Franzè E, Rizzo A, Rotondi A, Monteleone I, Fantini MC, Pallone F, Monteleone G.
    Mol Cancer Ther; 2011 Oct 01; 10(10):1969-81. PubMed ID: 21817114
    [Abstract] [Full Text] [Related]

  • 16. Butein sensitizes human hepatoma cells to TRAIL-induced apoptosis via extracellular signal-regulated kinase/Sp1-dependent DR5 upregulation and NF-kappaB inactivation.
    Moon DO, Kim MO, Choi YH, Kim GY.
    Mol Cancer Ther; 2010 Jun 01; 9(6):1583-95. PubMed ID: 20515942
    [Abstract] [Full Text] [Related]

  • 17. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
    Zhou X, Lv L, Tan Y, Zhang Z, Wei S, Xiao S.
    Brain Res; 2021 Sep 01; 1766():147515. PubMed ID: 33984327
    [Abstract] [Full Text] [Related]

  • 18. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
    Kim EO, Kang SE, Im CR, Lee JH, Ahn KS, Yang WM, Um JY, Lee SG, Yun M.
    Int J Oncol; 2016 May 01; 48(5):2205-12. PubMed ID: 26983803
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S, Yoshida T, Shiraishi T, Horinaka M, Kouhara J, Wakada M, Sakai T.
    Mol Cancer Ther; 2006 Jul 01; 5(7):1827-35. PubMed ID: 16891469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.